News | News By Subject | News by Disease News By Date | Search News

Diabetes News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
This Bay Area Biotech is Being Wooed by Drug Giant Novo Nordisk A/S (NVO)     3/10/2017
Oops, They Did it Again: Theranos Failed to Inform Patients of Potentially Botched Diabetes Test     2/14/2017
Top Harvard Scientist Retracts Diabetes Breakthrough Paper     1/4/2017
Many of Sanofi (SNY) Diabetes Layoffs Likely to be in Massachusetts     12/13/2016
Bernie Sanders Asks the DOJ to Investigate Eli Lilly (LLY), Novo Nordisk A/S (NVO) and Sanofi (SNY)     11/7/2016
New Setback Increases Sanofi (SNY)'s Hunger for a M&A     9/27/2016
Alphabet's Verily, Sanofi (SNY) Launch $500 Million Onduo, Joint Venture to Open New HQ in Kendall Square     9/13/2016
Adocia's Foot Ulcer Med Flunks Phase III Test     8/26/2016
Sanofi (SNY) Loses Lead on New Diabetes Drug After FDA Delay     8/22/2016
Evoke Pharma (EVOK) Stock Decimated After Late-Stage Trial Miss     7/19/2016
Novo Nordisk A/S (NVO) Investors Disappointed as Top Selling Drug Victoza Didn't Do as Well as Expected     6/14/2016
FDA Panel Unanimously Backs Novo Nordisk A/S (NVO)'s Diabetes Combo Drug Ideglira     5/25/2016
FDA Staff Questions Usefulness of Sanofi (SNY)’s Diabetes Drug Combo     5/23/2016
FDA Questions Study Findings, Practicality of Novo Nordisk A/S (NVO)'s Diabetes Drug Ideglira     5/23/2016
Intarcia Touts Large Phase III Trial Diabetes Data, Bags $75 Million     5/6/2016

News from Around the Web
3 Of The Most Promising Diabetes Meds From 5 Of The Most Innovative Biotechs In The World     3/27/2017
Is There A Link Between Climate Change And Diabetes? Leiden University Medical Center Study Reveals     3/21/2017
A Drug Company Just Struck A Deal To Discount The Price Of A Lifesaving Diabetes Medication To $25     3/17/2017
Bay Area's Livongo Rakes in $52.5 Million     3/17/2017
This Is Big News For Diabetics And Biotech Investors     3/2/2017
Meet The Woman Developing The Next Generation Of Insulin At Novo Nordisk A/S (NVO)     2/27/2017
Could A Little Bit Of Fasting Bring A Lot Of Health Benefits? University of Southern California Study     2/17/2017
Allergan (AGN) R&D Chief Reveals 6 Drugs That Could be Potential Blockbusters     2/14/2017
Insulin Makers Accused Of Price-Fixing In Class-Action Lawsuit     1/31/2017
San Francisco Biohackers Put On Diabetic Implants In The Pursuit Of "Human Enhancement," Nootrobox Reveals     1/20/2017
University of Twente Developing Portable Device For Early Diabetes Detection     1/11/2017
Stem Cells May Be Next Frontier for Diabetes Drugmaker Novo Nordisk A/S (NVO)     12/15/2016
New Device Promises Pain-Free Blood Draws For Glucose Testing     12/13/2016
Platypus Venom Could Be The Future Of Diabetes Treatments, University of Adelaide Study     12/9/2016
Detecting Inflammation In Diabetic Patients, Nanyang Technological University Study     12/9/2016

Press Releases
Novo Nordisk Canada Inc. (NVO) Release: New Fast-Acting Mealtime Insulin, Fiasp, Now Approved And Available In Canada For The Treatment Of Diabetes     3/27/2017
Berg Release: New Data Published In Nature Medicine From Joslin Diabetes Center Demonstrates The Importance Of Interrogating Human Biology     3/27/2017
DexCom (DXCM) Release: Medicare Announces Criteria Covering Dexcom G5 Mobile CGM For All People With Diabetes On Intensive Insulin Therapy     3/24/2017
Poxel SAS Announces Positive Results For Thorough QT Safety Clinical Study Of Imeglimin     3/21/2017
New Analysis Shows Novartis AG (NVS) Entresto Improves Glycemic Control In Reduced Ejection Fraction Heart Failure Patients With Diabetes     3/20/2017
ProtoKinetix Inc. (PKTX.OB) Announces Start Of Phase I & Phase II Clinical Trials For The Use Of AAGP PKX-001 Treated Islet Cells In The Treatment Of Type 1 Diabetes     3/9/2017
Virta Health Launches in the Bay Area With $37 Million     3/8/2017
Orgenesis Provides Update Regarding AIP Cell-Based Therapy For Type 1 Diabetes, Masthercell Cell Manufacturing Subsidiary And Overall Financial Condition     3/8/2017
City of Hope Release: Researchers Study Cure For Type 1 Diabetes In Stem Cell Transplantations     3/8/2017
Merck & Co. (MRK), Pfizer (PFE)'s 4-Year Diabetes Alliance Pays Off With FDA, EMA Filings     3/7/2017
Merck & Co. (MRK) And Pfizer (PFE) Announce FDA And EMA Filing Acceptances Of Three Marketing Applications For Ertugliflozin-Containing Medicines For Adults With Type 2 Diabetes     3/6/2017
AstraZeneca PLC (AZN) Release: FDA Approves Once-Daily QTERN (Dapagliflozin And Saxagliptin) Tablets For Adults With Type-2 Diabetes     2/28/2017
City of Hope Researchers Discover New Potential Cause Of Type 1 Diabetes     2/28/2017
Enrollment Completed In Ligand (LGND)’s Phase II Trial Of LGD-6972 In Type 2 Diabetes     2/27/2017
Valeritas Presents Data Showing Greater Reductions In A1c And Insulin Dose With V-Go Wearable Insulin Delivery Device Compared To Insulin Pen Devices In Patients With Type 2 Diabetes     2/17/2017

//-->